Home Equities Score In Pre-Market Session Today, Why Is The KZIA Stock Gaining Momentum?

In Pre-Market Session Today, Why Is The KZIA Stock Gaining Momentum?

Today, Kazia Therapeutics Limited (NASDAQ: KZIA) is moving higher on the charts in premarket trades. The KZIA stock is up more than 11.69% to trade at $12.42 as of the last check. Kazia Therapeutics stock closed the weekend session at $11.12 down -1.33%.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

During the past three months, the volume of KZIA shares traded was 153.95K, which was higher than the 0.13 million shares traded in the last session. The price of Kazia stock has been rising following news of a commercialization agreement for its lead product in greater China.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

What does the agreement cover?

Kazia Therapeutics Limited is an Australian-headquartered company that develops cancer treatments. Our leading program is paxalisib, a PI3K/Akt/mTOR inhibitor intended to treat glioblastoma, the most malignant primary brain cancer in adults. The clinical trial for paxalisib, a major advancement in the treatment of glioblastoma, began recruiting patients in January 2021.

Kazia Therapeutics today announced a licensing agreement with Simcere Pharmaceutical Group Ltd involving the development and commercialization of Kazia’s investigational new drug, paxalisib, in Greater China.

  • Mainland China, Hong Kong, Macau, and Taiwan are part of Greater China, and Simcere will be responsible for the development, registration, and commercialization of paxalisib in that region.
  • As with all other territories, Kazia retains all rights to develop and commercialize paxalisib, including in China.
  • Simcere is one of China’s fastest-growing pharmaceutical companies and has cancer, autoimmune disease, and neurological disorders its principal strategic areas of focus.
  • Paxalisib is currently the target of six additional clinical trials in other brain cancer types outside glioblastoma.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What will KZIA achieve?

The deal entails Kazia Therapeutics (KZIA) receiving an upfront payment of US$ 11 million (AU$ 14.2 million), comprising US$ 7 million in cash and US$ 4 million equity capital at a premium of 20% to recent trading. Further milestones in the US$ 281 million (AU$ 362) range will be paid for indications beyond glioblastoma. A mid-teen royalty will be paid to KZIA on commercial sales by Simcere as well. Paxalisib will be developed further using transaction proceeds.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

After The Market Close, Why Did Comscore (SCOR) Stock Start To Spike?

The shares of Comscore Inc. (NASDAQ: SCOR) rose 6.29% to $3.55 in Thursday's after-market session. Last trading session, Comscore stock lost -2.05%, closing at...

Here is how Meridian Bancorp Inc (EBSB) stock gained in after-hours session?

Meridian Bancorp Inc (EBSB) stock ended the normal trading session on Thursday, April 22, 2021, by losing 0.56% but it flipped and gained 16.95%...

Why Is The OPTT Stock Rising Today?

The shares of leading innovative and cost-effective ocean energy solutions provider Ocean Power Technologies Inc. (OPTT) have been trading up 3.54% in early trades...

IHT Stock Has Been Growing During Premarket Session. What Has Driven That Upward Trend?

At the premarket today, shares of InnSuites Hospitality Trust (NYSE: IHT) rose 10.43% to $2.33. The InnSuites stock gained 3.43% last trading day to finish...

In Premarket Session, Why Is SEAC Stock Rising?

Shares of SeaChange International Inc. (NASDAQ: SEAC) are trading up 11.65% to $1.15 in premarket. SEAC stock gained 1.98% to end Wednesday trading session...

What Made Clearfield (CLFD) Stock Trade High After Hours?

On Thursday, shares of the specialist in fiber management for communication service providers, Clearfield Inc. (NASDAQ: CLFD) rose 10.15 percent to $33.00 in after-hours...

Here Is Why The Silicon Labs (SLAB) Stock Was Up In Extended Trading?

After-market, shares of Silicon Laboratories Inc. (NASDAQ: SLAB) were up 12.34% to settle at $162.5. At the end of Thursday's regular trading, Silicon Laboratories...

How Could The Conformis (CFMS) Stock Rise More Than 10% In After-Hours?

After market hours on Thursday, shares of Conformis Inc. (NASDAQ: CFMS) rose 10.47% to $0.95. Conformis closed the regular trading session at $0.86, up...

Related News

How Could The Conformis (CFMS) Stock Rise More Than 10% In After-Hours?

After market hours on Thursday, shares of Conformis Inc. (NASDAQ: CFMS) rose 10.47% to $0.95. Conformis closed the regular trading session at $0.86, up...

Here is why Sypris Solutions, Inc.(SYPR) stock rallied in the after-hours on Thursday

Sypris Solutions, Inc.(SYPR) stock gained 42.35% in the after-market session on Thursday, April 22, 2021. Earlier, in the normal trading session, it gained 4.46%...

What Raised The OCGN Stock Higher In After-Hours Session?

In after-market trading hours on Wednesday, Ocugen Inc. (NASDAQ: OCGN) increased 7.85% in value to $7.01. A price range of $5.83 to $6.76 created...

Why did Neubase Therapeutics Inc (NBSE) stock slide in after-hours on Wednesday?

Neubase Therapeutics Inc (NBSE) stock started the day with a 3.09% gain on Wednesday, April 21, 2021, but in the after-hours session, it dropped...

Here is why Teradata Corporation (TDC) stock rallied in the after-market on Wednesday, April 21?

Teradata Corporation (TDC) stock surged 32.90% in the extended trading hours on Wednesday, April 21, 2021. Earlier TDC gained 2.92% in the normal trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.